We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$4.21B
AUM Growth
+$243M
Cap. Flow
+$12.7M
Cap. Flow %
0.3%
Top 10 Hldgs %
8.22%
Holding
1,288
New
116
Increased
426
Reduced
381
Closed
108

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$20.5M
2
NFLX icon
Netflix
NFLX
+$19.9M
3
COST icon
Costco
COST
+$18.6M
4
IBM icon
IBM
IBM
+$17.9M
5
PLTR icon
Palantir
PLTR
+$17.5M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$19.1M
2
QCOM icon
Qualcomm
QCOM
+$19.1M
3
CMCSA icon
Comcast
CMCSA
+$19.1M
4
INTC icon
Intel
INTC
+$19.1M
5
UPS icon
United Parcel Service
UPS
+$19M

Sector Composition

Rank Sector Weight
1 Financials 28.41%
2 Consumer Discretionary 12.52%
3 Industrials 11.69%
4 Technology 11.49%
5 Energy 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTEC icon
1126
Greenland Technologies Holding
GTEC
$14.3M
$59.7K ﹤0.01%
30,000
– –
SRFM icon
1127
Surf Air Mobility
SRFM
$90.5M
$58.8K ﹤0.01%
15,946
– –
FARM
1128
DELISTED
Farmer Brothers
FARM
$58.8K ﹤0.01%
42,900
– –
HYPR icon
1129
Hyperfine
HYPR
$96.3M
$57.4K ﹤0.01%
79,700
-25,000
-24% -$17.5K
ATNM icon
1130
Actinium Pharmaceuticals
ATNM
$23.8M
$56K ﹤0.01%
40,000
-35,000
-47% -$52.4K
GANX icon
1131
Gain Therapeutics
GANX
$76.4M
$54K ﹤0.01%
30,004
– –
IRWD icon
1132
Ironwood Pharmaceuticals
IRWD
$723M
$53.8K ﹤0.01%
75,000
+44,000
+142% +$34.5K
ARTV
1133
Artiva Biotherapeutics
ARTV
$531M
$52.9K ﹤0.01%
+35,000
New +$73.5K
NDLS icon
1134
Noodles & Co
NDLS
$106M
$52.1K ﹤0.01%
9,144
– –
IRBT
1135
DELISTED
iRobot
IRBT
$51.9K ﹤0.01%
16,586
– –
BOLD
1136
Boundless Bio
BOLD
$64.1M
$51K ﹤0.01%
+50,500
New +$67.1K
AIRG icon
1137
Airgain
AIRG
$73.9M
$47.3K ﹤0.01%
11,400
– –
OSTX
1138
OS Therapies Inc
OSTX
$72.4M
$47K ﹤0.01%
+25,000
New +$42.1K
PSQH icon
1139
PSQ Holdings
PSQH
$14.5M
$45.1K ﹤0.01%
1,467
– –
ANVS icon
1140
Annovis Bio
ANVS
$82.5M
$42.1K ﹤0.01%
19,400
– –
IRD
1141
Opus Genetics
IRD
$303M
$39.6K ﹤0.01%
42,065
-74,436
-64% -$69K
TXMD icon
1142
TherapeuticsMD
TXMD
$23.7M
$39.4K ﹤0.01%
34,000
– –
LOCL icon
1143
Local Bounti
LOCL
$23.3M
$38.7K ﹤0.01%
16,538
– –
BDSX icon
1144
Biodesix
BDSX
$236M
$38.7K ﹤0.01%
6,851
– –
NINE
1145
DELISTED
Nine Energy Service
NINE
$38.6K ﹤0.01%
50,000
– –
XLO icon
1146
Xilio Therapeutics
XLO
$59.8M
$38.1K ﹤0.01%
4,006
-1,071
-21% -$11.3K
CAMP icon
1147
CAMP4 Therapeutics
CAMP
$210M
$36.3K ﹤0.01%
+25,000
New +$49.8K
OCC icon
1148
Optical Cable Corp
OCC
$139M
$35.9K ﹤0.01%
12,600
-5,000
-28% -$14.4K
NRGV icon
1149
Energy Vault
NRGV
$571M
$35.8K ﹤0.01%
50,000
– –
RMCF icon
1150
Rocky Mountain Chocolate Factory
RMCF
$8.3M
$35.1K ﹤0.01%
24,566
– –
44 45
46
47 48

Similar funds

CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return
SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return

Bridgeway Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Bridgeway Capital Management held 1,288 positions worth $4.21B, up 6.1% from $3.97B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Bridgeway Capital Management's Q2 2025 filing shows 116 new, 426 increased, 381 reduced and 108 closed positions. Its largest new stake was AbbVie: 110,140 shares worth $20.4M. The largest sale was Pfizer, an estimated $19.1M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q2 2025 buy was AbbVie: 110,140 shares worth $20.4M.
  • Bridgeway Capital Management added most to Costco in Q2 2025, an estimated $18.6M increase.
  • Bridgeway Capital Management's biggest Q2 2025 reduction was Gulfport Energy Corp, cutting an estimated $14.8M.
  • Bridgeway Capital Management fully exited Pfizer in Q2 2025, selling an estimated $19.1M.
  • Bridgeway Capital Management's ten largest holdings make up 8.2% of its $4.21B portfolio in Q2 2025.
  • Bridgeway Capital Management opened 116 new positions and closed 108 in Q2 2025.
  • Bridgeway Capital Management's portfolio value rose 6.1% quarter-over-quarter to $4.21B.

Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.